- Home
- DVA vs WGSWW Comparison
DVA vs WGSWW Comparison
Compare DVA & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVA
- WGSWW
- Stock Information
- Founded
- DVA 1994
- WGSWW 2017
- Country
- DVA United States
- WGSWW United States
- Employees
- DVA N/A
- WGSWW 1000
- Industry
- DVA Misc Health and Biotechnology Services
- WGSWW Retail: Computer Software & Peripheral Equipment
- Sector
- DVA Health Care
- WGSWW Technology
- Exchange
- DVA Nasdaq
- WGSWW Nasdaq
- Market Cap
- DVA N/A
- WGSWW N/A
- IPO Year
- DVA 1995
- WGSWW N/A
- Fundamental
- Price
- DVA $143.76
- WGSWW $0.05
- Analyst Decision
- DVA Hold
- WGSWW
- Analyst Count
- DVA 4
- WGSWW 0
- Target Price
- DVA $159.75
- WGSWW N/A
- AVG Volume (30 Days)
- DVA 769.2K
- WGSWW 36.6K
- Earning Date
- DVA 05-12-2025
- WGSWW 02-18-2025
- Dividend Yield
- DVA N/A
- WGSWW N/A
- EPS Growth
- DVA 44.61
- WGSWW N/A
- EPS
- DVA 10.73
- WGSWW N/A
- Revenue
- DVA $12,815,550,000.00
- WGSWW $305,450,000.00
- Revenue This Year
- DVA $5.65
- WGSWW N/A
- Revenue Next Year
- DVA $3.65
- WGSWW N/A
- P/E Ratio
- DVA $13.36
- WGSWW N/A
- Revenue Growth
- DVA 5.56
- WGSWW 50.79
- 52 Week Low
- DVA $131.44
- WGSWW $0.17
- 52 Week High
- DVA $179.60
- WGSWW $0.21
- Technical
- Relative Strength Index (RSI)
- DVA 49.68
- WGSWW N/A
- Support Level
- DVA $138.67
- WGSWW N/A
- Resistance Level
- DVA $145.80
- WGSWW N/A
- Average True Range (ATR)
- DVA 2.91
- WGSWW 0.00
- MACD
- DVA 0.73
- WGSWW 0.00
- Stochastic Oscillator
- DVA 84.51
- WGSWW 0.00
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.